EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular Carcinoma

Fatema Safri iD, Russell Pickford, Yikun Xu, William Yang, Romario Nguyen iD, Lawrence Yuen, Vincent Lam, Christopher Nahm iD, Tony Pang iD, Jacob George iD, Liang Qiao iD

International Journal of Molecular Sciences · 06.07.2026 · 27 (13) · 6060

DOI: 10.3390/ijms27136060 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 06.07.2026. Verfasst von Fatema Safri und 10 weiteren Autor:innen. Beteiligte Einrichtung: Storr Liver Centre, The Westmead Institute for Medical Research, Westmead, Sydney, NSW 2145, Australia. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Lipids, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Robert W. Storr Bequest to the Sydney Medical Foundation, NSW Cancer Council, Cancer Institute NSW.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated fatty liver disease (MAFLD) is now the leading cause of hepatocellular carcinoma (HCC) globally. HCC surveillance is currently restricted to patients with cirrhosis, leaving those without cirrhosis, who present with more advanced disease and poorer outcomes without adequate risk stratification tools. This study compared lipid profiles across MAFLD and MAFLD-related HCC (MAFLD-HCC) patients, with and without cirrhosis, to characterise metabolic dysregulation underlying non-cirrhotic MAFLD-HCC (ncMAFLD-HCC). Plasma and liver lipidomic profiles were obtained from 221 patients (140 MAFLD, 66 cirrhotic MAFLD-HCC (cMAFLD-HCC), and 15 ncMAFLD-HCC) using untargeted liquid chromatography mass spectrometry. Univariate, multivariable and enrichment analyses were performed for statistically determining the lipid profile difference between the groups. Seventy percent of lipid classes were more abundant in MAFLD than in ncMAFLD-HCC and cMAFLD-HCC. Multivariate analysis revealed distinct lipid profiles across the three groups in both plasma and liver. Over 100 lipid species including diglyceride (DAG), sphingomyelin (SM), triglyceride (TG), dihydroceramide (DHCer), and linoleic acid derivatives were differentially expressed in ncMAFLD-HCC versus MAFLD, with enrichment in pathways such as glycerolipid metabolism, G-protein signalling, MAPK signalling, EGFR-TKI resistance pathway, implicated in HCC development. ncMAFLD-HCC exhibits a distinct lipid signature, offering preliminary mechanistic insight and a foundation for non-invasive biomarker development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsLipidsNon-alcoholic Fatty Liver DiseaseMetabolomeHumansFemaleMaleMiddle AgedLipidomicsLiverLiver CirrhosisLipid MetabolismAged

Stichwörter der Autor:innen

MAFLDcirrhosisfatty liverhepatocellular carcinomanon-cirrhotic MAFLD

Substanzen

Lipids

Autor:innen und Institutionen

  • Storr Liver Centre, The Westmead Institute for Medical Research, Westmead, Sydney, NSW 2145, Australia.
  • Faculty of Medicine and Health Sciences, The University of Sydney, Sydney, NSW 2050, Australia.
  • Bioanalytical Mass Spectrometry Facility, The University of New South Wales, Sydney, NSW 2052, Australia.
  • Department of Upper GI and HPB Surgery, Westmead Hospital, Westmead, NSW 2145, Australia.

ORCID-Profile: Fatema Safri, Romario Nguyen, Christopher Nahm, Tony Pang, Jacob George, Liang Qiao

Förderung

  • Robert W. Storr Bequest to the Sydney Medical Foundation
  • NSW Cancer Council
  • Cancer Institute NSW
  • NHMRC

Zitieren

APA

Safri, F., Pickford, R., Xu, Y., Yang, W., Nguyen, R., Yuen, L., Lam, V., Nahm, C., Pang, T., George, J., & Qiao, L. (2026). Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular Carcinoma. International Journal of Molecular Sciences, 27(13), 6060. https://doi.org/10.3390/ijms27136060

Vancouver

Safri F, Pickford R, Xu Y, Yang W, Nguyen R, Yuen L, et al. Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular Carcinoma. International Journal of Molecular Sciences. 2026;27(13):6060. doi:10.3390/ijms27136060

BibTeX
@article{Safri2026,
  author = {Safri, Fatema and Pickford, Russell and Xu, Yikun and Yang, William and Nguyen, Romario and Yuen, Lawrence and Lam, Vincent and Nahm, Christopher and Pang, Tony and George, Jacob and Qiao, Liang},
  title = {Integrated Plasma and Tissue Lipid Profiling Demonstrates a Distinctive Metabolic Profile in MAFLD-Associated Non-Cirrhotic Hepatocellular Carcinoma},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {13},
  pages = {6060},
  doi = {10.3390/ijms27136060}
}
Kostenlos starten →